icad Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
33,067.00
43,924.00
41,554.00
26,338.00
28,102.00
25,621
Cost of Goods Sold (COGS) incl. D&A
10,768.00
14,438.00
13,835.00
8,936.00
10,378.00
6,496
Gross Income
22,299.00
29,486.00
27,719.00
17,402.00
17,724.00
19,125
SG&A Expense
24,075.00
28,671.00
30,355.00
27,621.00
27,707.00
27,255
EBIT
1,776.00
815.00
2,636.00
10,219.00
9,983.00
8,130
Unusual Expense
2,448.00
932.00
29,166.00
249.00
6,693.00
-
Non Operating Income/Expense
-
-
-
-
2,508.00
-
Interest Expense
3,277.00
2,640.00
650.00
63.00
124.00
955
Pretax Income
7,482.00
856.00
32,431.00
10,023.00
14,274.00
8,975
Income Tax
126.00
153.00
16.00
76.00
18.00
42
Consolidated Net Income
7,608.00
1,009.00
32,447.00
10,099.00
14,256.00
9,017
Net Income
7,608.00
1,009.00
32,447.00
10,099.00
14,256.00
9,017
Net Income After Extraordinaries
7,608.00
1,009.00
32,447.00
10,099.00
14,256.00
9,017
Net Income Available to Common
7,608.00
1,009.00
32,447.00
10,099.00
14,256.00
9,017
EPS (Basic)
0.70
0.07
2.07
0.63
0.87
0.54
Basic Shares Outstanding
10,842.00
14,096.00
15,686.00
15,932.00
16,343.00
16,685
EPS (Diluted)
0.70
0.07
2.07
0.63
0.87
0.54
Diluted Shares Outstanding
10,842.00
14,096.00
15,686.00
15,932.00
16,343.00
16,685
EBITDA
654.00
4,341.00
712.00
7,914.00
8,494.00
7,422
Non-Operating Interest Income
19.00
37.00
21.00
10.00
18.00
110

About icad

View Profile
Address
98 Spit Brook Road
Nashua New Hampshire 03062
United States
Employees -
Website http://www.icadmed.com
Updated 07/08/2019
iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy business segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging.